BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 32865029)

  • 1. Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective.
    Lan H; Zhang W; Jin K; Liu Y; Wang Z
    Drug Deliv; 2020 Dec; 27(1):1248-1262. PubMed ID: 32865029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies.
    Liu Y; Guo J; Huang L
    Theranostics; 2020; 10(7):3099-3117. PubMed ID: 32194857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology.
    Bockamp E; Rosigkeit S; Siegl D; Schuppan D
    Cells; 2020 Sep; 9(9):. PubMed ID: 32942725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
    Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
    Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles for tumor immunotherapy.
    Zang X; Zhao X; Hu H; Qiao M; Deng Y; Chen D
    Eur J Pharm Biopharm; 2017 Jun; 115():243-256. PubMed ID: 28323111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of nanotechnology in circumventing immunotolerance.
    Ma Y; Shen Y; Zhu B; Li D; Liu J
    Pharmazie; 2020 Oct; 75(10):470-477. PubMed ID: 33305719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.
    Bader JE; Voss K; Rathmell JC
    Mol Cell; 2020 Jun; 78(6):1019-1033. PubMed ID: 32559423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective.
    Li Y; Ayala-Orozco C; Rauta PR; Krishnan S
    Nanoscale; 2019 Oct; 11(37):17157-17178. PubMed ID: 31531445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles.
    Zhang M; Kim JA; Huang AY
    Front Immunol; 2018; 9():341. PubMed ID: 29535722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
    Phuengkham H; Ren L; Shin IW; Lim YT
    Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy.
    Bai Y; Wang Y; Zhang X; Fu J; Xing X; Wang C; Gao L; Liu Y; Shi L
    Int J Pharm; 2019 Oct; 570():118636. PubMed ID: 31446027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy.
    Han S; Huang K; Gu Z; Wu J
    Nanoscale; 2020 Jan; 12(2):413-436. PubMed ID: 31829394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better.
    Thiruppathi J; Vijayan V; Park IK; Lee SE; Rhee JH
    Front Immunol; 2024; 15():1375767. PubMed ID: 38646546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy.
    Le QV; Suh J; Oh YK
    AAPS J; 2019 May; 21(4):64. PubMed ID: 31102154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy.
    Zhu Y; Yu X; Thamphiwatana SD; Zheng Y; Pang Z
    Acta Pharm Sin B; 2020 Nov; 10(11):2054-2074. PubMed ID: 33304779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
    Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
    Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy.
    Lim S; Park J; Shim MK; Um W; Yoon HY; Ryu JH; Lim DK; Kim K
    Theranostics; 2019; 9(25):7906-7923. PubMed ID: 31695807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes: Powerful weapon for cancer nano-immunoengineering.
    Pi YN; Xia BR; Jin MZ; Jin WL; Lou G
    Biochem Pharmacol; 2021 Apr; 186():114487. PubMed ID: 33647264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology Approaches to Improving Cancer Immunotherapy.
    Hagan CT; Medik YB; Wang AZ
    Adv Cancer Res; 2018; 139():35-56. PubMed ID: 29941106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.